Michael Christopher Jewett

Evanston, IL, United States of America

Michael Christopher Jewett

USPTO Granted Patents = 26 

Average Co-Inventor Count = 3.3

ph-index = 4

Forward Citations = 47(Granted Patents)


Company Filing History:


Years Active: 2016-2025

Loading Chart...
26 patents (USPTO):Explore Patents

Title: **Innovative Contributions of Michael Christopher Jewett in Bioconjugate Vaccination**

Introduction

Michael Christopher Jewett, based in Evanston, IL, is an accomplished inventor with a remarkable portfolio of 20 patents. His innovative work primarily focuses on bioconjugate vaccines, with particular emphasis on novel methods and compositions that enhance vaccine effectiveness.

Latest Patents

Jewett's latest patents include groundbreaking advancements such as "Compositions and methods for rapid in vitro synthesis of bioconjugate vaccines in vitro via production and N-glycosylation of protein carriers." This patent discloses methods and systems for cell-free synthesis of glycosylated carrier proteins, which can be utilized in vaccines, particularly in generating immune responses against bacterial polysaccharides. Another recent invention under his name is related to "Cell-free protein synthesis platforms derived from clostridia extracts," which involves compositions and kits for performing cell-free RNA transcription and protein synthesis using components from Clostridia species.

Career Highlights

Throughout his distinguished career, Jewett has held positions at prestigious institutions including Northwestern University and Cornell University. His research and innovations have significantly contributed to the fields of synthetic biology and immunology, making strides in vaccine technology.

Collaborations

Michael has collaborated with notable coworkers, including Jessica Carol Stark and Thapakorn Jaroentomeechai, whose collective expertise has further enhanced the impact of his research endeavors. These collaborations reflect Jewett's commitment to advancing scientific discovery through teamwork and shared insights.

Conclusion

In summary, Michael Christopher Jewett's contributions to the field of bioconjugate vaccines are notable, with his 20 patents showcasing the innovative methods he has developed. His work continues to pave the way for advancements in immunization strategies, ultimately aiming to improve public health outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…